CÚRAM is part of a new EU research project TBMED (Test bed for high-risk medical devices), which aims to support European Medtech companies in global competition by reducing the time-to-market of high-risk medical devices. An Open Innovation test bed for the development of devices of risk classification IIb and higher will provide expert support from an early development stage to the optimised transformation of prototypes into valuable and innovative products. The project has received €8.5 million in funding from the European Union’s Horizon 2020 Framework Programme and will run for a period of over four years.
CÚRAM, the Science Foundation Ireland Centre for Research in Medical Devices based at NUI Galway is one of 13 European partners in the TBMED project, which sets out to tackle two of the most pressing issues in the EU healthcare system – the large variation in patient diagnosis and continually increasing costs which result in an urgent need to create and incorporate value in healthcare. However, new EU regulations regarding medical devices classified as high-risk impose great challenges especially on smaller European production companies which are the core target group of TBMED. In order to help Small to Medium Enterprises (SMEs) to deliver better care at more reasonable costs and enable them to face global competition by large suppliers, the consortium aims to develop an Open Innovation test bed focusing on the most challenging devices of high-risk classification IIb upwards.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
